1:31 PM
Dec 19, 2017
 |  BC Innovations  |  Distillery Therapeutics


INDICATION: Short bowel syndrome

A bioengineered intestinal transplant could help treat short bowel syndrome. The transplant consists of a decellularized segment of rat proximal jejunum seeded with human endothelial cells and human induced pluripotent stem (iPS) cell-derived intestinal epithelial...

Read the full 167 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >